Dimensional Fund Advisors
TNGX icon

Dimensional Fund Advisors’s Tango Therapeutics TNGX Stock Holding History

Dimensional Fund Advisors’s Portfolio TNGX Stock Details TNGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$15.3M Sell
488,300
-1,048
-0.2% -$25.9K ﹤0.01% 2149
2026
Q1 		$10.2M Buy
489,348
+2,272
+0.5% +$31.6K ﹤0.01% 2252
2025
Q4 		$4.32M Sell
487,076
-185,659
-28% -$1.6M ﹤0.01% 2570
2025
Q3 		$5.65M Buy
672,735
+147,637
+28% +$999K ﹤0.01% 2510
2025
Q2 		$2.69M Sell
525,098
-80,192
-13% -$198K ﹤0.01% 2686
2025
Q1 		$830K Sell
605,290
-57,486
-9% -$141K ﹤0.01% 2912
2024
Q4 		$2.05M Buy
662,776
+302,087
+84% +$1.4M ﹤0.01% 2781
2024
Q3 		$2.78M Buy
360,689
+24,776
+7% +$236K ﹤0.01% 2703
2024
Q2 		$2.88M Buy
335,913
+100,257
+43% +$775K ﹤0.01% 2666
2024
Q1 		$1.87M Buy
235,656
+175,742
+293% +$1.88M ﹤0.01% 2809
2023
Q4 		$593K Hold
59,914
– – ﹤0.01% 3014
2023
Q3 		$675K Buy
+59,914
New +$365K ﹤0.01% 2999

Other funds holding TNGX

RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
BCM
Boxer Capital Management San Diego, California $1.33B AUM 864.5% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return

Dimensional Fund Advisors's TNGX Position: Q2 2026 in Review

Dimensional Fund Advisors reduced its Tango Therapeutics (TNGX) stake by 0.21% in Q2 2026, selling an estimated $25.9K and leaving 488,300 shares worth $15.3M. The position accounts for ﹤0.01% of the portfolio, ranked #2149.

Dimensional Fund Advisors first reported a position in TNGX in Q3 2023 and has held it in 12 quarters since. 248 funds tracked by Wall St. Rank hold TNGX as of Q2 2026.

  • Dimensional Fund Advisors held 488,300 shares of Tango Therapeutics worth $15.3M as of Q2 2026.
  • Dimensional Fund Advisors sold 1,048 Tango Therapeutics shares in Q2 2026, an estimated $25.9K.
  • Tango Therapeutics made up ﹤0.01% of Dimensional Fund Advisors's portfolio in Q2 2026, its #2149 holding.
  • Dimensional Fund Advisors first reported a position in Tango Therapeutics in Q3 2023 and has held it in 12 quarters since.
  • 248 funds tracked by Wall St. Rank held Tango Therapeutics as of Q2 2026.

Based on Dimensional Fund Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.